panaxadiol has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SM; Feng, YY; He, JL; Li, Y; Tian, SY | 1 |
1 other study(ies) available for panaxadiol and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Ginseng-derived panaxadiol ameliorates STZ-induced type 1 diabetes through inhibiting RORĪ³/IL-17A axis.
Topics: Animals; Diabetes Mellitus, Type 1; Drug Inverse Agonism; Interleukin-17; Ligands; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; Panax | 2023 |